A recent analysis, published in The Lancet Oncology, calculates that increasing access to [¹⁷⁷Lu]PSMA therapy for eligible patients could generate $725 million in economic potential. This impact is projected across nine selected countries between 2023 and 2029.
Medical Xpress – latest medical and health news stories
